• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声控制的白蛋白结合脂质体用于乳腺癌治疗。

Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.

机构信息

a Department of Chemical Engineering , American University of Sharjah , Sharjah , UAE.

b Department of Biology, Chemistry and Environmental Sciences , American University of Sharjah , Sharjah , UAE.

出版信息

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):705-714. doi: 10.1080/21691401.2019.1573175.

DOI:10.1080/21691401.2019.1573175
PMID:30873869
Abstract

Targeted liposomes have high potentials in the specific and effective delivery of their loaded therapeutic agents to the tumour site. Once at the tumour site, it is important that these liposomes are triggered to release their load in a controlled and effective manner. In this study, pegylated (stealth) liposomes conjugated to human serum albumin (HSA) were investigated for the delivery of a model drug (calcein) to breast cancer cells. The fluorescent results showed that calcein uptake by the two breast cancer cell lines (MDA-MB-231 and MCF-7) was significantly higher with the HSA-PEG liposomes compared to the non-targeted control liposomes. Furthermore, the exposure to low-frequency ultrasound (LFUS) resulted in a statistically significant uptake of calcein compared to the uptake without ultrasound. The described drug delivery (DD) system, which involves combining the targeted liposomal formulation with ultrasonic triggering techniques, promises a safe, effective and site-specific breast cancer therapy.

摘要

靶向脂质体在将其负载的治疗剂特异性和有效地递送到肿瘤部位方面具有很大的潜力。一旦到达肿瘤部位,重要的是这些脂质体被触发以可控和有效的方式释放其负载。在这项研究中,研究了与人血清白蛋白(HSA)缀合的聚乙二醇化(隐形)脂质体用于递送模型药物(钙黄绿素)至乳腺癌细胞。荧光结果表明,与非靶向对照脂质体相比,两种乳腺癌细胞系(MDA-MB-231 和 MCF-7)对 HSA-PEG 脂质体的钙黄绿素摄取明显更高。此外,与没有超声的摄取相比,低频超声(LFUS)的暴露导致钙黄绿素摄取的统计学显著增加。所描述的药物递送(DD)系统,涉及将靶向脂质体制剂与超声触发技术相结合,有望实现安全、有效和靶向的乳腺癌治疗。

相似文献

1
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.超声控制的白蛋白结合脂质体用于乳腺癌治疗。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):705-714. doi: 10.1080/21691401.2019.1573175.
2
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.超声控制的雌酮修饰脂质体用于雌激素阳性乳腺癌治疗。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):462-472. doi: 10.1080/21691401.2018.1459634. Epub 2018 Apr 12.
3
Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.聚乙二醇化和靶向部分对脂质体超声介导的药物释放的影响。
ACS Biomater Sci Eng. 2020 Jan 13;6(1):48-57. doi: 10.1021/acsbiomaterials.8b01301. Epub 2019 Jul 3.
4
Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound.利用超声触发的透明质酸偶联脂质体靶向治疗乳腺癌。
J Biomed Nanotechnol. 2021 Jan 1;17(1):90-99. doi: 10.1166/jbn.2021.3012.
5
Ultrasound-triggered herceptin liposomes for breast cancer therapy.超声触发曲妥珠单抗脂质体用于乳腺癌治疗。
Sci Rep. 2021 Apr 6;11(1):7545. doi: 10.1038/s41598-021-86860-5.
6
Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.用于开发主动靶向肿瘤的多柔比星脂质体载体的工程肽。
Cancer Lett. 2013 Jul 1;334(2):284-92. doi: 10.1016/j.canlet.2012.10.007. Epub 2012 Oct 13.
7
PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.靶向表达 α5β1 的 MDA-MB-231 乳腺癌细胞的 PEG 化脂质体阿霉素。
Langmuir. 2012 Mar 13;28(10):4729-36. doi: 10.1021/la204466g. Epub 2012 Feb 29.
8
PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.聚乙二醇化透明质酸包覆脂质体通过主动靶向肿瘤细胞和延长系统暴露来增强索拉非尼的体内疗效。
Nanomedicine. 2018 Feb;14(2):557-567. doi: 10.1016/j.nano.2017.12.003. Epub 2017 Dec 14.
9
Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes.聚焦超声对载有钙黄绿素的热敏隐形脂质体的影响。
Int J Hyperthermia. 2015 Jun;31(4):349-58. doi: 10.3109/02656736.2014.1000393. Epub 2015 Feb 13.
10
New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.新型叶酸修饰的人血清白蛋白与阳离子脂质载体偶联用于米托蒽醌双重靶向治疗乳腺癌。
Curr Pharm Biotechnol. 2020;21(4):305-315. doi: 10.2174/1389201020666191114113022.

引用本文的文献

1
Predicting Calcein Release from Ultrasound-Targeted Liposomes: A Comparative Analysis of Random Forest and Support Vector Machine.超声靶向脂质体中 calcein 释放的预测:随机森林和支持向量机的比较分析。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241296725. doi: 10.1177/15330338241296725.
2
Encapsulation and release of calcein from herceptin-conjugated eLiposomes.钙黄绿素从赫赛汀偶联的e脂质体中的包封与释放。
Heliyon. 2024 Mar 13;10(6):e27882. doi: 10.1016/j.heliyon.2024.e27882. eCollection 2024 Mar 30.
3
Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers.
超声响应纳米载体增强乳腺癌的靶向治疗。
Int J Mol Sci. 2023 Mar 13;24(6):5474. doi: 10.3390/ijms24065474.
4
Modeling of the In Vitro Release Kinetics of Sonosensitive Targeted Liposomes.超声敏感靶向脂质体的体外释放动力学建模
Biomedicines. 2022 Dec 5;10(12):3139. doi: 10.3390/biomedicines10123139.
5
Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.基于脂质体载体的癌症治疗响应性药物递送研究进展
Pharmaceutics. 2022 Oct 15;14(10):2195. doi: 10.3390/pharmaceutics14102195.
6
Ultrasound-Triggered Liposomes Encapsulating Quantum Dots as Safe Fluorescent Markers for Colorectal Cancer.超声触发的包裹量子点的脂质体作为结直肠癌的安全荧光标记物
Pharmaceutics. 2021 Dec 3;13(12):2073. doi: 10.3390/pharmaceutics13122073.
7
Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I.基于脂质体的心肌肌钙蛋白 I 检测免疫分析的建立。
Molecules. 2021 Nov 19;26(22):6988. doi: 10.3390/molecules26226988.
8
Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications.超声响应性诊疗纳米材料综述:作用机制、结构及医学应用
Beilstein J Nanotechnol. 2021 Aug 11;12:808-862. doi: 10.3762/bjnano.12.64. eCollection 2021.
9
Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.癌症治疗中的双靶点与刺激触发脂质体药物递送
ACS Pharmacol Transl Sci. 2021 Jun 1;4(3):1028-1049. doi: 10.1021/acsptsci.1c00066. eCollection 2021 Jun 11.
10
Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.超声触发转铁蛋白修饰脂质体治疗 HeLa 细胞。
Sci Rep. 2021 Jun 2;11(1):11589. doi: 10.1038/s41598-021-90349-6.